Today: 27 January 2026
Subscribe
Browse Category

Stock Market News 24 December 2025

Home Depot Stock (HD) News Today, Dec. 24, 2025: Price Action, Analyst Forecasts, and What Investors Are Watching

Home Depot Stock (HD) News Today, Dec. 24, 2025: Price Action, Analyst Forecasts, and What Investors Are Watching

Home Depot, Inc. (NYSE: HD) is trading through a shortened Christmas Eve session with investors juggling mixed signals: upbeat Wall Street ratings, cautious earnings-revision trends, and a steady drumbeat of institutional-position headlines. Meanwhile, the broader market’s “Santa rally” narrative is picking up steam as the S&P 500 notched a fresh record intraday high on Wednesday. Reuters As of the latest…
24 December 2025
····
Procter & Gamble (PG) Stock Today: Analyst Upgrades, Tariff Pressures, and a CEO Change Set the Tone for 2026

Procter & Gamble (PG) Stock Today: Analyst Upgrades, Tariff Pressures, and a CEO Change Set the Tone for 2026

December 24, 2025 — Procter & Gamble (NYSE: PG) is ending 2025 in a familiar role for markets: a defensive bellwether that investors watch closely for clues about consumer demand, pricing power, and how quickly households are trading down—or trading up—when the economy gets choppy. On December 24, 2025, with U.S. markets operating in a holiday-shortened session and broad indexes…
24 December 2025
····
Polestar Stock (PSNY) Surges on Fresh Funding: Latest News, Analyst Forecasts, and What Investors Are Watching (Dec. 24, 2025)

Polestar Stock (PSNY) Surges on Fresh Funding: Latest News, Analyst Forecasts, and What Investors Are Watching (Dec. 24, 2025)

Polestar Automotive Holding UK PLC (Nasdaq: PSNY) is back in the market spotlight on December 24, 2025, with the stock rallying sharply as investors digest a string of balance-sheet moves designed to extend liquidity, reduce leverage, and keep the company’s Nasdaq listing in good standing. Business Wire The quick version: PSNY traded around $17.09, up roughly 13% on the day,…
24 December 2025
····
Merck Stock Forecast and News Roundup for December 24, 2025: MRK Hits a New 52-Week High as Wall Street Reprices 2026 Catalysts

Merck Stock Forecast and News Roundup for December 24, 2025: MRK Hits a New 52-Week High as Wall Street Reprices 2026 Catalysts

Merck & Company, Inc. stock is ending 2025 on a strong note. On December 24, 2025, shares of Merck (MRK) pushed to a fresh 12‑month high around the $106 level, extending a powerful late‑year rally that has put the pharma bellwether back in the spotlight. MarketBeat This move isn’t happening in a vacuum. Today’s MRK price action sits at the…
24 December 2025
···
Edgewise Therapeutics Stock (EWTX) Jumps on EDG-7500 CIRRUS-HCM Update: Dec. 24, 2025 News, Analyst Forecasts, and Key Catalysts

Edgewise Therapeutics Stock (EWTX) Jumps on EDG-7500 CIRRUS-HCM Update: Dec. 24, 2025 News, Analyst Forecasts, and Key Catalysts

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) stock surged in intraday trading on Wednesday, December 24, 2025, after the company released a fresh update on EDG-7500, its investigational therapy for hypertrophic cardiomyopathy (HCM). By late morning, shares were trading around $26.37—up roughly 21% versus the prior close—after swinging between about $21.30 and $27.05 on the day, with volume above 2.2 million shares.…
24 December 2025
····
Johnson & Johnson Stock Today: JNJ Holds Near $207 on Dec. 24, 2025 as Talc Verdict, Drug-Price Pressure and Q4 Earnings Take Center Stage

Johnson & Johnson Stock Today: JNJ Holds Near $207 on Dec. 24, 2025 as Talc Verdict, Drug-Price Pressure and Q4 Earnings Take Center Stage

Johnson & Johnson (NYSE: JNJ) is trading through a holiday-shortened Christmas Eve session with investors balancing a familiar mix of defensive appeal and headline risk. On Wednesday, December 24, 2025, J&J shares hovered around $207 in late-morning trade, keeping the healthcare bellwether close to its recent highs even as the company faces fresh legal scrutiny and renewed policy pressure on…
24 December 2025
····
Citigroup Stock News (NYSE: C) on Dec. 24, 2025: Regulatory Relief, Banamex Progress, and Wall Street Forecasts for 2026

Citigroup Stock News (NYSE: C) on Dec. 24, 2025: Regulatory Relief, Banamex Progress, and Wall Street Forecasts for 2026

NEW YORK — Citigroup, Inc. (NYSE: C) is closing out 2025 with a resurgence that has put C stock back on many investors’ watchlists. In the holiday-shortened session on Wednesday, Dec. 24, 2025, Wall Street traded close to record territory amid thin volumes, while bank shares remained in focus after a string of December headlines around regulatory progress, strategic streamlining,…
24 December 2025
····
ServiceNow Stock (NYSE: NOW) News Today: $7.75B Armis Deal, CEO Contract Extension, and 2026 Analyst Forecasts (Dec. 24, 2025)

ServiceNow Stock (NYSE: NOW) News Today: $7.75B Armis Deal, CEO Contract Extension, and 2026 Analyst Forecasts (Dec. 24, 2025)

ServiceNow, Inc. (NYSE: NOW) is back in the spotlight on December 24, 2025, as investors weigh two major developments: the company’s $7.75 billion all-cash agreement to acquire cybersecurity firm Armis and a new CEO contract extension for Bill McDermott through 2030. Add in the recent 5‑for‑1 stock split that reset the share price and made older price targets harder to…
24 December 2025
···
Warner Bros. Discovery (WBD) Series A Stock: Latest News, Deal Battle Updates, and Wall Street Forecasts on Dec. 24, 2025

Warner Bros. Discovery (WBD) Series A Stock: Latest News, Deal Battle Updates, and Wall Street Forecasts on Dec. 24, 2025

Warner Bros. Discovery, Inc. Series A Common Stock (NASDAQ: WBD) is ending 2025 as one of the most deal-driven names in U.S. media—caught between a signed Netflix agreement and an aggressive, sweetened hostile bid from Paramount Skydance. On December 24, 2025, WBD shares traded around $29.18, positioning the stock neatly between Netflix’s $27.75 per share cash-and-stock structure (plus a planned…
24 December 2025
····
Exxon Mobil Stock (XOM) News and Forecast for Dec. 24, 2025: Sakhalin-1 Deadline Extended, Oil Prices Rebound, and Analysts See More Upside

Exxon Mobil Stock (XOM) News and Forecast for Dec. 24, 2025: Sakhalin-1 Deadline Extended, Oil Prices Rebound, and Analysts See More Upside

Exxon Mobil Corporation stock (NYSE: XOM) traded around $119.62 in holiday-thinned action on Wednesday, Dec. 24, 2025, as investors balanced a fresh geopolitical headline tied directly to Exxon’s long-running Russia exit, a late-December rebound in crude prices, and a steady drumbeat of analyst targets clustering in the low $130s. With U.S. markets operating on a shortened Christmas Eve session (stocks…
24 December 2025
····
Robinhood Stock (NASDAQ: HOOD) News Today: Holiday Trading, Prediction-Markets Push, and Wall Street Price Targets on Dec. 24, 2025

Robinhood Stock (NASDAQ: HOOD) News Today: Holiday Trading, Prediction-Markets Push, and Wall Street Price Targets on Dec. 24, 2025

December 24, 2025 Robinhood Markets, Inc. stock (NASDAQ: HOOD) is trading in a holiday-shortened Christmas Eve session, with markets set to close early and volumes expected to stay thin. In that kind of tape, even modest moves in crypto prices and risk appetite can show up quickly across retail-brokerage and crypto-exposed names—especially a stock like Robinhood, which has become one…
24 December 2025
····
Clearwater Analytics (CWAN) Stock on Dec. 24, 2025: $24.55 Take-Private Deal, Latest Analyst Forecasts, and Key Dates to Watch

Clearwater Analytics (CWAN) Stock on Dec. 24, 2025: $24.55 Take-Private Deal, Latest Analyst Forecasts, and Key Dates to Watch

Clearwater Analytics Holdings, Inc. (NYSE: CWAN) isn’t trading like a typical software stock on December 24, 2025. It’s trading like a deal. As of today, CWAN is around $24.14, with shares moving in a tight range that reflects a simple market reality: Clearwater has agreed to be acquired for $24.55 per share in cash, so the stock is now largely…
24 December 2025
····
1 … 785 786 787 788 789 … 1,654

Stock Market Today

  • Health Catalyst's New Price Target Reshapes Market Expectations and Fair Value
    January 27, 2026, 8:34 AM EST. Health Catalyst (NasdaqGS:HCAT) draws renewed investor attention as a fresh analyst price target sets a new benchmark for the stock's fair value. This reset offers a standalone reference point amid evolving views on the company's growth prospects, profitability timeline, and balance sheet health. Investors are encouraged to weigh this figure alongside their own risk assessments before judging current share prices. Trading above or below this target signals where market expectations differ from analysts' valuations but does not guarantee future returns. Tracking future price target revisions will reveal shifts in analyst optimism or caution. Simply Wall St's Community platform offers a dynamic space for investors to explore narratives that tie Health Catalyst's financials to its long-term business outlook, enabling continual updates as new data emerges.
Go toTop